Rationale and design of a UK database for a rare cancer type: the GEM Registry for gastrointestinal stromal tumours. - Wikidata - awgldk - TriplyDB

Rationale and design of a UK database for a rare cancer type: the GEM Registry for gastrointestinal stromal tumours.

Rationale and design of a UK database for a rare cancer type: the GEM Registry for gastrointestinal stromal tumours.

http://www.wikidata.org/entity/Q37182168

about

Big Data: the challenge for small research groups in the era of cancer genomics The End-of-Life Experience of Patients With Rare Cancers and Their Caregivers.What are the essential features of a successful surgical registry? a systematic review.

P2860

Q26780460-2B2D9EB3-14AE-482F-AC89-8A035E54E560 Q37687391-6F63F0FB-2A08-4105-A4A8-73983E5A14EA Q42177550-77F7161F-7A02-4A4B-9BB7-A977C66A4DB6

P2860

Rationale and design of a UK database for a rare cancer type: the GEM Registry for gastrointestinal stromal tumours.

http://www.wikidata.org/entity/Q37182168

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Rationale and design of a UK d ...... trointestinal stromal tumours.

@en

Rationale and design of a UK d ...... trointestinal stromal tumours.

@nl

type

label

Rationale and design of a UK d ...... trointestinal stromal tumours.

@en

Rationale and design of a UK d ...... trointestinal stromal tumours.

@nl

prefLabel

Rationale and design of a UK d ...... trointestinal stromal tumours.

@en

Rationale and design of a UK d ...... trointestinal stromal tumours.

@nl

P1433

Q37182168-9EE21704-35DB-42ED-AB23-BD8878FE0062

P1476

Q37182168-8E7EDB14-8A41-406D-AE15-A8E38DCC9F39

P2093

Q37182168-26957A19-7D5C-4F8B-B239-93B132E810B7

Q37182168-820FF68A-26AD-4725-9B4C-66F2C3727A92

Q37182168-8A789EB9-A2DC-4DEB-86A2-17D0322E568D

Q37182168-9B44D9F3-EDBD-4161-82BA-9757521E6DC4

Q37182168-9B7D3005-BCAE-4147-8EEF-3230C0492173

Q37182168-A894D2C5-F2D1-413E-9E57-1F17DC28451E

Q37182168-C0DF8547-7DC3-44F5-9FF3-7CDB22D4F550

Q37182168-CDA8A350-5236-4FC0-AC14-2635F31F9667

Q37182168-E15E9051-087A-47EC-B3A2-DB254376AA8E

P2860

Q37182168-0016E79E-C56B-4781-AE3A-D994517A48FF

Q37182168-0660C15D-54CB-4758-B527-33CBA5F69ED4

Q37182168-0FCAAE33-7946-4340-A2F8-465A0495EDC2

Q37182168-1C418E36-859E-46D1-A3AE-8AFC5B27C080

Q37182168-2A0C9C26-1BA5-47C9-8EC9-BE08DD7D9E51

Q37182168-2DFC71D5-5006-4809-B8A1-5D086E500D92

Q37182168-44485E40-6970-40CA-84F0-60ECED8029F9

Q37182168-527D7104-88C0-4F22-B197-3608FAECF40A

Q37182168-5518F6C8-0BF9-41C0-8B92-D9E742F8BFD2

Q37182168-5B2A1F88-0128-49AD-A116-D714DC472CED

P2888

Q37182168-B0E0997B-84F9-46D3-8F4F-1833363394DF

P304

Q37182168-1160B79E-CD1D-45CD-9DD4-FD742C8BD13E

P31

Q37182168-52BC53D8-3089-4A03-BE35-C42080AA4672

P356

Q37182168-EAD42D38-BBEC-4DC8-9822-1D98B5C4E52B

P407

Q37182168-437906EE-A0CD-4F95-AD4D-B6539D559B35

P433

Q37182168-6B3D54E3-24AB-4D4E-B9B5-2A1001EDD1B3

P478

Q37182168-6C3164C7-6865-443F-9B59-3DB8C57D3599

P50

Q37182168-8B9D47CA-1B85-419E-A5C7-9656BEDBC950

P577

Q37182168-6DFB671E-0B5F-4948-9543-63A8432E6A54

P5875

Q37182168-0241C00E-C222-487F-872D-D7A5A0EE219B

P698

Q37182168-B5AC0A4D-C589-4997-BC66-BF4FE5C4384A

P921

Q37182168-37BAE678-BF61-4FFE-8003-B75897312E27

P932

Q37182168-3DC6FBFE-C64E-4B96-BD20-590C43ADEE96

P356

P1433

British Journal of Cancer

P1476

Rationale and design of a UK d ...... strointestinal stromal tumours

@en

P2093

A Rasheed

http://www.w3.org/2001/XMLSchema#string

C Morgan

http://www.w3.org/2001/XMLSchema#string

I Judson

http://www.w3.org/2001/XMLSchema#string

J Fullarton

http://www.w3.org/2001/XMLSchema#string

J White

http://www.w3.org/2001/XMLSchema#string

M Verrill

http://www.w3.org/2001/XMLSchema#string

P Taniere

http://www.w3.org/2001/XMLSchema#string

S Toh

http://www.w3.org/2001/XMLSchema#string

V R Bulusu

http://www.w3.org/2001/XMLSchema#string

P2860

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis

Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.

Duration of first off-treatment interval is prognostic for time to castration resistance and death in men with biochemical relapse of prostate cancer treated on a prospective trial of intermittent androgen deprivation.

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.

Pediatric and wild-type gastrointestinal stromal tumor: new therapeutic approaches.

Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread.

Survival of gastrointestinal stromal tumor patients in the imatinib era: life raft group observational registry.

Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

P2888

P304

1403-1407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2013.406

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256074101

http://www.w3.org/2001/XMLSchema#string

P698

23963143

http://www.w3.org/2001/XMLSchema#string

P921

P932

3776973

http://www.w3.org/2001/XMLSchema#string